ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Daily Humidification Improves Quality-of-Life in Phase III Trial

February 28, 2014

MSKCC Wins Zoning Request For New Labs.

February 8, 2002

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

November 4, 1994

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

International Group Plans Survey On Thrombosis Risk

July 27, 2001

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976